Myovant Sciences NYSE MYOV
- - -%
Today share price
UK
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 25 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

2.61B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

2.57B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

2.83
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

96.86M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-
Upcoming events Myovant Sciences All events
No upcoming events scheduled

Stock chart Myovant Sciences

Stock analysis Myovant Sciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-14.22 58.16
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-5.52 27.30
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-17.87 14.49
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.32 2.05
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
32.93 46.94

Price change Myovant Sciences per year

13.59$ 29.71$
Min Max

Summary analysis Myovant Sciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Myovant Sciences

Revenue and net income Myovant Sciences

All parameters
Stock news Myovant Sciences All news

Myovant Sciences downgraded to hold from outperform at Evercore ISI

Myovant Sciences Accepts Sweetened $2.9 Billion Bid From Sumitomo Pharma

Myovant Sciences shares trading higher after agreeing to Sumitomo deal for $2.9 billion

Myovant Sciences Shares Rise Premarket on Sumitomo Takeover >MYOV

Myovant Sciences Shares Rise Premarket on Sumitomo Takeover >MYOV

Myovant Sciences Shares Surge Premarket After Spurned Sumitomo Bid >MYOV

Myovant Sciences Shares Surge Premarket After Spurned Sumitomo Bid >MYOV

Myovant Sciences: Sumitovant Biopharma Offer 'Significantly Undervalues the Company'

Myovant Sciences: Sumitovant Biopharma Offer 'Significantly Undervalues the Company'

Myovant Sciences Shares Rise 14% After 4Q Results

Myovant Sciences Shares Rise 14% After 4Q Results

Myovant Sciences Stk Hits 52-Week Low After FDA Notice for Myfembree

Myovant Sciences Stk Hits 52-Week Low After FDA Notice for Myfembree

Myovant Sciences Shares Drop 20% After FDA Notice for Myfembree

Myovant Sciences Shares Drop 20% After FDA Notice for Myfembree

Myovant Sciences Gets Positive CHMP Opinion for Cancer Treatment

Myovant Sciences Gets Positive CHMP Opinion for Cancer Treatment

-Лидеры и аутсайдеры Уолл-cтрит: Broadcom, SAExploration, Myovant Sciences

About company Myovant Sciences

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, for the treatment of female infertility as part of assisted reproduction and is under phase 2 clinical trial. Myovant Sciences Ltd. has collaboration with Pfizer Inc. to develop and commercialize relugolix in oncology and women's health. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was incorporated in 2016 and is based in London, the United Kingdom. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd.
Address:
11-12 St. James?s Square, London, United Kingdom, SW1Y 4LB
Company name: Myovant Sciences
Issuer ticker: MYOV
ISIN: BMG637AM1024
Country: UK
Exchange: NYSE
Currency: $
IPO date: 2016-10-27
Sector: Healthcare
Industry: Biotechnology
Site: https://myovant.com

On which stock exchange are Myovant Sciences (MYOV) stocks traded?

Myovant Sciences (MYOV) stocks are traded on NYSE.

What is the ticker of Myovant Sciences stocks (MYOV)?

The stock ticker of Myovant Sciences’s stocks or in other words, the code is MYOV. The stocks are currently listed on the NYSE exchange.

In which sector and industry does Myovant Sciences (MYOV) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Myovant Sciences (MYOV) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Myovant Sciences (MYOV) stocks traded?

Myovant Sciences (MYOV) stocks are traded on the NYSE exchange in dollars.

What is the price of Myovant Sciences (MYOV) stocks today?

The current price of Myovant Sciences stocks on 29.04.2024 is dollars. per share.

What is the dynamics of Myovant Sciences (MYOV) stocks from the beginning of the year?

Myovant Sciences (MYOV) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Myovant Sciences (MYOV) stocks increase in апреле 2024?

This month Myovant Sciences (MYOV) quotes have increased by 0% to dollars. per share.

How much are Myovant Sciences (MYOV) stocks worth?

Today, on October, 29.04.2024 Myovant Sciences’s (MYOV) stocks cost dollars..

What is the market capitalization of Myovant Sciences (MYOV)?

Capitalization is the market value of Myovant Sciences (MYOV) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Myovant Sciences (MYOV) is estimated at about 2613258734 dollars.